FMO4

Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia

Dimethylaniline monooxygenase [N-oxide-forming] 4 is an enzyme in humans encoded by the FMO4 gene.[5][6]

AliasesFMO4, FMO2, flavin containing monooxygenase 4, flavin containing dimethylaniline monoxygenase 4
End171,342,084 bp[1]
Quick facts Identifiers, Aliases ...
FMO4
Identifiers
AliasesFMO4, FMO2, flavin containing monooxygenase 4, flavin containing dimethylaniline monoxygenase 4
External IDsOMIM: 136131; MGI: 2429497; HomoloGene: 68219; GeneCards: FMO4; OMA:FMO4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002022

NM_144878

RefSeq (protein)

NP_002013

NP_659127

Location (UCSC)Chr 1: 171.31 – 171.34 MbChr 1: 162.62 – 162.64 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Function

Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria. Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region. Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics.[6]

Cancer

FMO4 gene has been observed progressively downregulated in Human papillomavirus-positive neoplastic keratinocytes derived from uterine cervical preneoplastic lesions at different levels of malignancy.[7] For this reason, FMO4 is likely to be associated with tumorigenesis and may be a potential prognostic marker for uterine cervical preneoplastic lesions progression.[7]

References

Further reading

Related Articles

Wikiwand AI